Related Experiment Video

Updated: Jun 15, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

[Predictors of changes in drug regimens for treating AIDS in children]

Cristina Ribeiro Macedo1, Diana de Oliveira Frauches, Laylla Ribeiro Macedo

  • 1Escola Superior de Ciências da Santa Casa de Misericórdia de Vitória, Vitória, ES. cristinarmacedo@gmail.com

Revista Da Sociedade Brasileira De Medicina Tropical
|March 9, 2010
PubMed

Insights

Drug intolerance, not adherence, most often necessitates changes in antiretroviral therapy for children with AIDS. Increased viral load and poor response also drive treatment adjustments.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Clinical pharmacology

Context:

  • Vertical transmission of Human Immunodeficiency Virus (HIV) in children presents unique treatment challenges.
  • Antiretroviral therapy (ART) regimens require adjustments to optimize outcomes and manage adverse events.
  • Understanding factors influencing ART changes is crucial for effective pediatric HIV management.

Purpose:

  • To investigate the primary reasons for modifying antiretroviral therapy (ART) in children with Acquired Immunodeficiency Syndrome (AIDS) who acquired HIV through vertical transmission.
  • To identify specific clinical and immunological indicators that prompt changes in treatment regimens.
  • To determine the relative contribution of various factors, including drug intolerance and adherence, to ART modifications.

Summary:

  • A case-control study analyzed 62 children with ART changes and 49 controls between 2000-2005.
  • Key drivers for regimen modification included increased viral load (48.4%), poor immunological response (46.6%), and clinical worsening (35.5%).
  • Logistic regression identified drug intolerance as the most significant factor influencing medication changes (adjusted OR: 79.94).

Impact:

  • Drug intolerance emerged as the predominant factor necessitating ART changes in vertically HIV-infected children.
  • Patient adherence was not found to be a significant cause for ART regimen modification.
  • Effective management relies on robust service organization and interdisciplinary team collaboration to address treatment challenges.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.